FDA Drug recall D-0292-2021
Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE
- FDA Drug
- Class II
- terminated
- Published 2021-03-10
On 2021-03-10 the FDA classified a Class II recall of Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE by Dr Reddy S Laboratories, citing failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0292-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-02-26 |
| Published | 2021-03-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Progesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy's Laboratories, Inc., Princeton, NJ 08540; NDC 43598-350-01.
Reason
Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.
Identifiers
| ndc | 43598-349-01 |
|---|---|
| ndc | 43598-350-01 |
| code_info | Batch # 1399851P1, Exp 02/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0292-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.